Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · IEX Real-Time Price · USD
9.25
-0.18 (-1.91%)
At close: Jul 26, 2024, 4:00 PM
9.26
+0.01 (0.11%)
After-hours: Jul 26, 2024, 6:28 PM EDT

Iovance Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2013
Net Income
-449.64-444.04-395.89-342.25-259.58-197.56
Upgrade
Depreciation & Amortization
27.4723.2621.1413.988.718.12
Upgrade
Other Amortization
9.879.87----
Upgrade
Loss (Gain) From Sale of Assets
-----0.02
Upgrade
Asset Writedown & Restructuring Costs
--0.4---
Upgrade
Loss (Gain) From Sale of Investments
-4.96-3.610.476.011.87-3.42
Upgrade
Stock-Based Compensation
64.1462.6384.0269.7740.8924.28
Upgrade
Other Operating Activities
-4.91-3.41----0.34
Upgrade
Change in Accounts Receivable
-0.23-0.15----
Upgrade
Change in Inventory
-16.85-10.12----
Upgrade
Change in Accounts Payable
-4.014.835.886.98-2.9612.71
Upgrade
Change in Other Net Operating Assets
-5.14-1.08-8.7817.585.95-2.7
Upgrade
Operating Cash Flow
-384.28-361.82-292.76-227.94-205.13-158.89
Upgrade
Capital Expenditures
-20.8-22.29-20.43-37.57-46.79-6.92
Upgrade
Cash Acquisitions
-265.21-212.63----
Upgrade
Investment in Securities
-134.1479.68276.8837.71-271.0696.94
Upgrade
Investing Cash Flow
-420.14-155.24256.460.13-317.8590.03
Upgrade
Long-Term Debt Issued
---1--
Upgrade
Total Debt Issued
---1--
Upgrade
Net Debt Issued (Repaid)
---1--
Upgrade
Issuance of Common Stock
403.93465.75192.8238.27576.716.44
Upgrade
Repurchase of Common Stock
-5.57-2.8-2.65--0.28-0.31
Upgrade
Financing Cash Flow
398.36462.96190.15239.27576.426.13
Upgrade
Foreign Exchange Rate Adjustments
-3.23-2.74----
Upgrade
Net Cash Flow
-409.3-56.84153.8511.4653.44-62.73
Upgrade
Free Cash Flow
-405.08-384.11-313.18-265.52-251.93-165.81
Upgrade
Free Cash Flow Margin
-21275.26%-32305.30%----
Upgrade
Free Cash Flow Per Share
-1.63-1.63-1.97-1.73-1.82-1.33
Upgrade
Levered Free Cash Flow
-231.84-211.47-173.54-129.35-141.4-88.94
Upgrade
Unlevered Free Cash Flow
-231.84-211.47-173.54-129.35-141.4-88.94
Upgrade
Change in Net Working Capital
20.37-2.928.97-38.67-19.5-14.87
Upgrade
Source: S&P Capital IQ. Standard template.